Young Cancer Survivors May Struggle With Social Functioning

Article

When someone faces a cancer diagnosis during the period of social maturation, the impacts can be lasting, according to a recent study.

Adjusting to life after a cancer diagnosis is not always easy for young patients, according to a recent study published in the journal, CANCER, which found that adolescent and young adult (AYA) cancer survivors may see slight improvements about a year after their diagnosis, but their social functioning hits a plateau after that, leaving them lagging behind their cancer-free peers.

In a multicenter longitudinal study, 141 AYA patients who were between the ages of 14 and 39 at diagnosis had their social functioning measured (via a self-reported measure) at diagnosis, 12 months and then 24 months after.

“Social functioning for recently diagnosed AYA patients with cancer was worse when compared to population norms,” study author Olga Husson, Ph.D., of the Radboud University Medical Centre in the Netherlands said in an interview with CURE. “Although it improved somewhat over the two years following diagnosis, social functioning remained significantly lower compared to population norms after 24 months.”

Nearly one-third of survivors — many who were off-treatment and transitioning into their life after cancer — reported consistently low social function over time. As these individuals go from patient to survivor, they may be apprehensive about their future. This includes negative impacts from cancer on their financial situation, body image, work plans, relationships with a spouse/significant other and plans for having children, Husson said.

Additionally, survivors who scored low reported more physical symptoms and higher levels of psychological distress, and reported that they felt they had less social support.

In the study, 9 percent of participants had consistently high/normal social functioning; 47 percent had improved social functioning; 13 percent had worsening social functioning; and about 32 percent had consistently low social functioning.

This population is particularly vulnerable to suffering the social effects of a cancer diagnosis, as the disease may come at a time that hinders social maturation, Husson explained. This is when people develop their self-views, social cognition, awareness and emotional regulation.

“AYAs with cancer frequently report difficulties in maintaining or making new social relationships because of long-term effects of cancer treatment (hindering reintegration into school or work) or feeling anxious about ‘fitting into’ their peer group again,” Husson said.

However, Husson mentioned that there are steps that can be taken to improve social function in young survivors. For example, AYA patients may benefit from supportive care interventions or therapy. And as mentioned earlier, taking care of the physical pain can have an effect, too.

“Reducing physical symptoms and psychological distress and enhancing social support by intervention in the period after treatment may potentially help these young survivors to better reintegrate into society,” Husson said.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content